Home・Aktien・IQVIA Holdings Inc

IQVIA Holdings Inc

Geschlossen

BrancheGesundheitswesen

236.14 -2.23

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

237.02

Max

243.97

Schlüsselkennzahlen
By Trading Economics
Einkommen	-17M 258M
Verkäufe	217M 4.4B
KGV Branchendurchschnitt	30.137 57.002
EPS	2.75
Gewinnspanne	5.907
Angestellte	94,000
EBITDA	-18M 790M

Empfehlungen
By TipRanks
Empfehlungen	Starkes Kaufsignal
12-Monats-Prognose	+13.12% upside

Dividenden
By Acuity
Nächstes Ergebnis	27. Okt. 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	4.2B 40B
Vorheriger Eröffnungskurs	238.37
Vorheriger Schlusskurs	236.14

Nachrichtenstimmung

By Acuity

50%

152 / 340 Ranking in Healthcare

IQVIA Holdings Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Peer-Vergleich

Kursveränderung

IQVIA Holdings Inc Prognose

Kursziel

By TipRanks

13.12% Vorteil

12-Monats-Prognose

Durchschnitt 273.43 USD 13.12%

Hoch 300 USD

Tief 240 USD

Basierend auf 16 Wall-Street-Analysten, die in den letzten 3 Monaten 12-Monats-Kursziele für IQVIA Holdings Inc – Dist angeboten haben.

Rating-Konsens

By TipRanks

Starkes Kaufsignal

16 ratings

Buy

Halten

Sell

Basierend auf 16 Analysten, die in den letzten 3 Monaten Aktienbewertungen für IQVIA Holdings Inc – Dist abgegeben haben.

Stimmung

By Acuity

152 / 340 Ranking in Gesundheitswesen

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über IQVIA Holdings Inc

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients' outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services. This segment also provides country level performance metrics related to sales of pharmaceutical products, prescribing trends, medical treatment, and promotional activity across various channels, including retail, hospital, and mail order; and measurement of sales or prescribing activity at the regional, zip code, and individual prescriber level. The Research & Development Solutions segment offers project management and clinical monitoring; clinical trial support; strategic planning and design services; and patient and site centric solutions, as well as central laboratory, genomic, bioanalytical, ADME, discovery, and vaccine and biomarker laboratory services. The Contract Sales & Medical Solutions segment provides health care provider and patient engagement services, and scientific strategy and medical affairs services. It serves pharmaceutical, biotechnology, device and diagnostic, and consumer health companies. The company has a collaboration with argenx SE; and a strategic collaboration with NVIDIA Corporation. The company was formerly known as Quintiles IMS Holdings, Inc. and changed its name to IQVIA Holdings Inc. in November 2017. The company is headquartered in Durham, North Carolina.